We’re proud to share that IVRS AB and Succipro S.L. have received Eurostars funding to develop a new biologic therapy for Crohn’s disease, an important
Exciting news! IVRS AB is proud to be a key partner in the NIAC consortium, recently awarded a €1.36M Eurostars grant for groundbreaking renal cell
We are thrilled to launch our new model of Non-Small Cell Lung Cancer. We use patient-derived xenografts as well as mouse allografts to replicate clinical
We proudly announce that IVRS AB has been appointed to Industry Winner 2024 within Biotechnical Research and Development! Branschvinnare i Sverige AB awards this title
We continue growing!
We are excited to launch our new orthotopic model of human glioblastoma. We use cutting-edge technology such as patient-derived xenografts (PDX) and in vivo bioluminescence
Do you want to learn more about our work and how we can help you?
Visit us
